Goal-directed fluid therapy in major elective rectal surgery.

Area of Science:

• Anesthesiology and Perioperative Medicine
• Surgical Outcomes Research
• Critical Care Medicine

Background:

• Goal-Directed Fluid Therapy (GDFT) is established for major colorectal surgery but lacks specific data for rectal surgery.
• Previous studies suggest GDFT may reduce complications and hospital length of stay.
• The applicability and efficacy of GDFT in modern rectal surgery require investigation.

Purpose of the Study:

• To investigate the clinical benefits of GDFT in patients undergoing major elective rectal surgery.
• To determine if GDFT impacts 30-day total complications and hospital length of stay.
• To compare fluid administration volumes between GDFT and conventional fluid management.

Main Methods:

• A cohort study of 81 patients undergoing major elective rectal surgery.
• Twenty-seven patients received GDFT using Oesophageal Doppler Monitor (ODM); 54 patients served as a historical control group.
• Primary endpoint: 30-day total complications; Secondary endpoints: hospital length of stay (LOS) and fluid volumes.

Main Results:

• No significant differences in total complications (81% vs. 81%) or median hospital LOS (9 vs. 10 days) between groups.
• GDFT group received higher initial colloid boluses (1000 mL vs. 500 mL) but similar intraoperative total fluid volumes (3000 mL vs. 3000 mL).
• A non-significant trend suggested decreased 24-hour fluid requirement in the GDFT group (p=0.06).

Conclusions:

• Intraoperative GDFT did not demonstrate significant improvements in clinical outcomes for major elective rectal surgery.
• The study did not find GDFT to be superior to conventional fluid management in this specific patient population.
• Further research may be needed to explore potential benefits of GDFT in specific subgroups or with different protocols.